Skip to main content
Erschienen in: European Radiology 5/2019

06.12.2018 | Hepatobiliary-Pancreas

New MRI features improve subtype classification of hepatocellular adenoma

verfasst von: Sylvain Bise, Nora Frulio, Arnaud Hocquelet, Nicolas Alberti, Jean-Frederic Blanc, Christophe Laurent, Hervé Laumonier, Charles Balabaud, Paulette Bioulac-Sage, Hervé Trillaud

Erschienen in: European Radiology | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Objective

MRI is crucial for the classification of hepatocellular adenomas (HCA) into subtypes. Our objective was to review and increase MRI criteria for subtype classification and define the limits.

Methods

Pathological and radiological data of 116 HCAs were retrospectively analyzed to investigate MRI features of HCA pathological subtypes. Risk for complication was also evaluated with regard to subtype and tumor size.

Results

38/43 (88%) HNF1α-mutated HCAs (H-HCAs) were discriminated by (i) fatty component (homogeneous or heterogeneous) and (ii) hypovascular pattern, with a sensitivity of 88% and a specificity of 97%. 51/58 (88%) inflammatory HCAs (IHCAs) displayed features of sinusoidal dilatation (SD) including three different patterns (global SD, atoll sign, and a new “crescent sign” corresponding to a partial peripheral rim, hyperintense on T2W and/or arterial phase with persistent delayed enhancement). Sensitivity was 88% and specificity 100%. However, some HCA remained unclassifiable by MRI: HCA remodeled by necrotic/hemorrhagic changes covering > 50% of the lesion, H-HCAs without steatosis, IHCAs without SD, β-catenin-mutated and unclassified HCAs. Regarding malignant transformation (5/116) and bleeding (24/116), none was observed when the HCA diameter was smaller than 5.2 cm and 4.2 cm, respectively.

Conclusion

Based on the largest series evaluated until now, we identified several non-described MRI features and propose new highly sensitive and specific MRI criteria. With the addition of these new features, 88% of the two main HCA subtypes could be identified.

Key Points

• HNF1α-mutated hepatocellular adenomas (H-HCA) are characterized by the presence of fat and hypovascular pattern in MRI.
• Inflammatory hepatocellular adenomas (I-HCA) are characterized by different patterns translating sinusoidal dilatation including the newly described crescent sign.
• No MRI specific pattern was identified for β-catenin-mutated HCA (b-HCA).
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Rooks JB, Ory HW, Ishak KG et al (1979) Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 242:644–648CrossRefPubMed Rooks JB, Ory HW, Ishak KG et al (1979) Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 242:644–648CrossRefPubMed
2.
Zurück zum Zitat Nault JC, Bioulac-Sage P, Zucman-Rossi J (2013) Hepatocellular benign tumors-from molecular classification to personalized clinical care. Gastroenterology 144:888–902CrossRefPubMed Nault JC, Bioulac-Sage P, Zucman-Rossi J (2013) Hepatocellular benign tumors-from molecular classification to personalized clinical care. Gastroenterology 144:888–902CrossRefPubMed
3.
Zurück zum Zitat Bioulac-Sage P, Rebouissou S, Thomas C et al (2007) Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46:740–748CrossRefPubMed Bioulac-Sage P, Rebouissou S, Thomas C et al (2007) Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46:740–748CrossRefPubMed
4.
Zurück zum Zitat Bioulac-Sage P, Balabaud C, Zucman-Rossi J (2010) Subtype classification of hepatocellular adenoma. Dig Surg 27:39–45CrossRefPubMed Bioulac-Sage P, Balabaud C, Zucman-Rossi J (2010) Subtype classification of hepatocellular adenoma. Dig Surg 27:39–45CrossRefPubMed
5.
Zurück zum Zitat Paradis V, Benzekri A, Dargère D et al (2004) Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 126:1323–1329CrossRefPubMed Paradis V, Benzekri A, Dargère D et al (2004) Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 126:1323–1329CrossRefPubMed
6.
Zurück zum Zitat Bioulac-Sage P, Rebouissou S, Sa Cunha A et al (2005) Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 128:1211–1218CrossRefPubMed Bioulac-Sage P, Rebouissou S, Sa Cunha A et al (2005) Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 128:1211–1218CrossRefPubMed
7.
Zurück zum Zitat Rebouissou S, Amessou M, Couchy G et al (2009) Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 457:200–204CrossRefPubMed Rebouissou S, Amessou M, Couchy G et al (2009) Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 457:200–204CrossRefPubMed
8.
Zurück zum Zitat Pilati C, Amessou M, Bihl MP et al (2011) Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas. J Exp Med 208:1359–1366CrossRefPubMedPubMedCentral Pilati C, Amessou M, Bihl MP et al (2011) Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas. J Exp Med 208:1359–1366CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Nault JC, Fabre M, Couchy G et al (2012) GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. J Hepatol 56:184–191CrossRefPubMed Nault JC, Fabre M, Couchy G et al (2012) GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. J Hepatol 56:184–191CrossRefPubMed
10.
Zurück zum Zitat Bioulac-Sage P, Laumonier H, Couchy G et al (2009) Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 50:481–489CrossRefPubMed Bioulac-Sage P, Laumonier H, Couchy G et al (2009) Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 50:481–489CrossRefPubMed
11.
Zurück zum Zitat Zucman-Rossi J, Jeannot E, Nhieu JT et al (2006) Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43:515–524CrossRefPubMed Zucman-Rossi J, Jeannot E, Nhieu JT et al (2006) Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43:515–524CrossRefPubMed
12.
Zurück zum Zitat Stoot JH, Coelen RJ, De Jong MC, Dejong CH (2010) Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) 12:509–522CrossRef Stoot JH, Coelen RJ, De Jong MC, Dejong CH (2010) Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) 12:509–522CrossRef
13.
Zurück zum Zitat Van der Borght S, Libbrecht L, Katoonizadeh A et al (2007) Nuclear beta-catenin staining and absence of steatosis are indicators of hepatocellular adenomas with an increased risk of malignancy. Histopathology 51:855–856CrossRefPubMed Van der Borght S, Libbrecht L, Katoonizadeh A et al (2007) Nuclear beta-catenin staining and absence of steatosis are indicators of hepatocellular adenomas with an increased risk of malignancy. Histopathology 51:855–856CrossRefPubMed
14.
Zurück zum Zitat Nault JC, Couchy G, Balabaud C et al (2017) Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation. Gastroenterology 152:880–894 e6CrossRefPubMed Nault JC, Couchy G, Balabaud C et al (2017) Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation. Gastroenterology 152:880–894 e6CrossRefPubMed
15.
Zurück zum Zitat Henriet E, Abou Hammoud A, Dupuy JW et al (2017) Argininosuccinate synthase 1 (ASS1): a marker of unclassified hepatocellular adenoma and high bleeding risk. Hepatology 66:2016–2028CrossRefPubMed Henriet E, Abou Hammoud A, Dupuy JW et al (2017) Argininosuccinate synthase 1 (ASS1): a marker of unclassified hepatocellular adenoma and high bleeding risk. Hepatology 66:2016–2028CrossRefPubMed
16.
Zurück zum Zitat Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H (2008) Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 48:808–818CrossRefPubMed Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H (2008) Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 48:808–818CrossRefPubMed
17.
Zurück zum Zitat Ronot M, Bahrami S, Calderaro J et al (2011) Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology 53:1182–1191CrossRefPubMed Ronot M, Bahrami S, Calderaro J et al (2011) Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology 53:1182–1191CrossRefPubMed
18.
Zurück zum Zitat van Aalten SM, Thomeer MG, Terkivatan T et al (2011) Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology 261:172–181CrossRefPubMed van Aalten SM, Thomeer MG, Terkivatan T et al (2011) Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology 261:172–181CrossRefPubMed
19.
Zurück zum Zitat Grazioli L, Olivetti L, Mazza G, Bondioni MP (2013) MR imaging of hepatocellular adenomas and differential diagnosis dilemma. Int J Hepatol 2013:374170CrossRefPubMedPubMedCentral Grazioli L, Olivetti L, Mazza G, Bondioni MP (2013) MR imaging of hepatocellular adenomas and differential diagnosis dilemma. Int J Hepatol 2013:374170CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Wu JS, Hochman MG (2009) Soft-tissue tumors and tumorlike lesions: a systematic imaging approach. Radiology 253:297–316CrossRefPubMed Wu JS, Hochman MG (2009) Soft-tissue tumors and tumorlike lesions: a systematic imaging approach. Radiology 253:297–316CrossRefPubMed
21.
Zurück zum Zitat Salaria SN, Graham RP, Aishima S, Mounajjed T, Yeh MM, Torbenson MS (2015) Primary hepatic tumors with myxoid change: morphologically unique hepatic adenomas and hepatocellular carcinomas. Am J Surg Pathol 39:318–324CrossRefPubMed Salaria SN, Graham RP, Aishima S, Mounajjed T, Yeh MM, Torbenson MS (2015) Primary hepatic tumors with myxoid change: morphologically unique hepatic adenomas and hepatocellular carcinomas. Am J Surg Pathol 39:318–324CrossRefPubMed
22.
Zurück zum Zitat Merkle EM, Nelson RC (2006) Dual gradient-echo in-phase and opposed-phase hepatic MR imaging: a useful tool for evaluating more than fatty infiltration or fatty sparing. Radiographics 26:1409–1418CrossRefPubMed Merkle EM, Nelson RC (2006) Dual gradient-echo in-phase and opposed-phase hepatic MR imaging: a useful tool for evaluating more than fatty infiltration or fatty sparing. Radiographics 26:1409–1418CrossRefPubMed
23.
Zurück zum Zitat Bieze M, Phoa SS, Verheij J, van Lienden KP, van Gulik TM (2014) Risk factors for bleeding in hepatocellular adenoma. Br J Surg 101:847–855CrossRefPubMed Bieze M, Phoa SS, Verheij J, van Lienden KP, van Gulik TM (2014) Risk factors for bleeding in hepatocellular adenoma. Br J Surg 101:847–855CrossRefPubMed
24.
Zurück zum Zitat DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRefPubMed DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRefPubMed
25.
Zurück zum Zitat Tse JR, Naini BV, Lu DS, Raman SS (2016) Qualitative and quantitative gadoxetic acid-enhanced MR imaging helps subtype hepatocellular adenomas. Radiology 279:118–127CrossRefPubMed Tse JR, Naini BV, Lu DS, Raman SS (2016) Qualitative and quantitative gadoxetic acid-enhanced MR imaging helps subtype hepatocellular adenomas. Radiology 279:118–127CrossRefPubMed
26.
Zurück zum Zitat Ishii M, Kazaoka J, Fukushima J et al (2015) A case of beta-catenin-positive hepatocellular adenoma with MR imaging sign of diffuse intratumoral fat deposition. Abdom Imaging 40:1487–1491CrossRefPubMed Ishii M, Kazaoka J, Fukushima J et al (2015) A case of beta-catenin-positive hepatocellular adenoma with MR imaging sign of diffuse intratumoral fat deposition. Abdom Imaging 40:1487–1491CrossRefPubMed
27.
Zurück zum Zitat Yoneda N, Matsui O, Kitao A et al (2012) Beta-catenin-activated hepatocellular adenoma showing hyperintensity on hepatobiliary-phase gadoxetic-enhanced magnetic resonance imaging and overexpression of OATP8. Jpn J Radiol 30:777–782CrossRefPubMed Yoneda N, Matsui O, Kitao A et al (2012) Beta-catenin-activated hepatocellular adenoma showing hyperintensity on hepatobiliary-phase gadoxetic-enhanced magnetic resonance imaging and overexpression of OATP8. Jpn J Radiol 30:777–782CrossRefPubMed
28.
Zurück zum Zitat Ba-Ssalamah A, Antunes C, Feier D et al (2015) Morphologic and molecular features of hepatocellular adenoma with gadoxetic acid-enhanced MR imaging. Radiology 277:104–113CrossRefPubMed Ba-Ssalamah A, Antunes C, Feier D et al (2015) Morphologic and molecular features of hepatocellular adenoma with gadoxetic acid-enhanced MR imaging. Radiology 277:104–113CrossRefPubMed
29.
Zurück zum Zitat Guo Y, Li W, Cai W, Zhang Y, Fang Y, Hong G (2017) Diagnostic value of gadoxetic acid-enhanced MR imaging to distinguish HCA and its subtype from FNH: a systematic review. Int J Med Sci 14:668–674CrossRefPubMedPubMedCentral Guo Y, Li W, Cai W, Zhang Y, Fang Y, Hong G (2017) Diagnostic value of gadoxetic acid-enhanced MR imaging to distinguish HCA and its subtype from FNH: a systematic review. Int J Med Sci 14:668–674CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Belghiti J, Cauchy F, Paradis V, Vilgrain V (2014) Diagnosis and management of solid benign liver lesions. Nat Rev Gastroenterol Hepatol 11:737–749CrossRefPubMed Belghiti J, Cauchy F, Paradis V, Vilgrain V (2014) Diagnosis and management of solid benign liver lesions. Nat Rev Gastroenterol Hepatol 11:737–749CrossRefPubMed
31.
Zurück zum Zitat Dokmak S, Paradis V, Vilgrain V et al (2009) A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 137:1698–1705CrossRefPubMed Dokmak S, Paradis V, Vilgrain V et al (2009) A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 137:1698–1705CrossRefPubMed
32.
Zurück zum Zitat van Aalten SM, de Man RA, IJzermans JN, Terkivatan T (2012) Systematic review of haemorrhage and rupture of hepatocellular adenomas. Br J Surg 99:911–916CrossRefPubMed van Aalten SM, de Man RA, IJzermans JN, Terkivatan T (2012) Systematic review of haemorrhage and rupture of hepatocellular adenomas. Br J Surg 99:911–916CrossRefPubMed
33.
Zurück zum Zitat Bioulac-Sage P, Sempoux C, Possenti L et al (2013) Pathological diagnosis of hepatocellular cellular adenoma according to the clinical context. Int J Hepatol 2013:253261PubMedPubMedCentral Bioulac-Sage P, Sempoux C, Possenti L et al (2013) Pathological diagnosis of hepatocellular cellular adenoma according to the clinical context. Int J Hepatol 2013:253261PubMedPubMedCentral
34.
Zurück zum Zitat Sempoux C, Paradis V, Komuta M et al (2015) Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders. J Hepatol 63:1173–1180CrossRefPubMed Sempoux C, Paradis V, Komuta M et al (2015) Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders. J Hepatol 63:1173–1180CrossRefPubMed
35.
Zurück zum Zitat Agnello F, Ronot M, Valla DC, Sinkus R, Van Beers BE, Vilgrain V (2012) High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis. Radiology 262:511–519CrossRefPubMed Agnello F, Ronot M, Valla DC, Sinkus R, Van Beers BE, Vilgrain V (2012) High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis. Radiology 262:511–519CrossRefPubMed
36.
Metadaten
Titel
New MRI features improve subtype classification of hepatocellular adenoma
verfasst von
Sylvain Bise
Nora Frulio
Arnaud Hocquelet
Nicolas Alberti
Jean-Frederic Blanc
Christophe Laurent
Hervé Laumonier
Charles Balabaud
Paulette Bioulac-Sage
Hervé Trillaud
Publikationsdatum
06.12.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 5/2019
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-018-5784-5

Weitere Artikel der Ausgabe 5/2019

European Radiology 5/2019 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.